Ritholtz Wealth Management
RVMD icon

Ritholtz Wealth Management’s Revolution Medicines RVMD Stock Holding History

Ritholtz Wealth Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$920K Buy
4,480
+429
+11% +$85K 0.01% 662
2026
Q2 		$759K Buy
4,051
+326
+9% +$47.6K 0.01% 704
2026
Q1 		$362K Buy
+3,725
New +$376K 0.01% 906

Other funds holding RVMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Ritholtz Wealth Management's RVMD Position: Q3 2026 in Review

Ritholtz Wealth Management increased its Revolution Medicines (RVMD) stake by 11% in Q3 2026, buying an estimated $85K and bringing the position to 4,480 shares worth $920K. The position accounts for 0.01% of the portfolio, ranked #662.

Ritholtz Wealth Management first reported a position in RVMD in Q1 2026 and has held it in 3 quarters since. 496 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Ritholtz Wealth Management held 4,480 shares of Revolution Medicines worth $920K as of Q3 2026.
  • Ritholtz Wealth Management bought 429 Revolution Medicines shares in Q3 2026, an estimated $85K.
  • Revolution Medicines made up 0.01% of Ritholtz Wealth Management's portfolio in Q3 2026, its #662 holding.
  • Ritholtz Wealth Management first reported a position in Revolution Medicines in Q1 2026 and has held it in 3 quarters since.
  • 496 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Ritholtz Wealth Management's 13F filing for Q3 2026, filed 5 Nov 2026.